CD274 and neoplasm: To evaluate the pharmacodynamics of LZFPN-90 in vivo, we selected the A20 cell line to construct a tumor-bearing mouse model, which was because the A20 cell line has high PD-L1 expression and a relatively high NAD+ content (Appendix Fig. S5A).